Description
BLOOD AND BLOOD PRODUCTS
First action · last action
2023-03-01 · 2024-06-05
Transactions
4
First transaction's obligation
$263,557
Base + all options value (sum of deltas)
$1,040,029
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24419D0035
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-03-01+$263,557= $263,557
- Mod P000012023-04-25+$1,390= $264,947
- Mod P000022024-03-27+$13,025= $277,972
- Mod P000032024-06-05-$115,659= $162,313
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-03-01 | +$263,557 | $263,557 | BLOOD AND BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2023-04-25 | +$1,390 | $264,947 | BLOOD AND BLOOD PRODUCTS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-03-27 | +$13,025 | $277,972 | BLOOD AND BLOOD PRODUCTS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-05 | −$115,659 | $162,313 | BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GE17LEU396S3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N0493 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $253,134 | FY2026 |
| 36C24426D0048 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24425N0378 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $124,141 | FY2025 |
| 36C24424D0042 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C24424N0449 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $163,336 | FY2024 |
| 36C24422N0276 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6810 · CHEMICALS | $166,065 | FY2022 |
Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24426D0097 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $0 | FY2026 |
| 36C24426N0938 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $650,641 | FY2026 |
| 36C24426N0948 | ERA HEALTH LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $29,590 | FY2026 |
| 36C24426P0339 | NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $126,204 | FY2026 |
| 36C24426N0663 | LUMINEX CORP | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $121,316 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24423N0440_3600_36C24419D0035_3600 · retrieved 2026-09-26.